
Sign up to save your podcasts
Or


What can we be doing to reduce LDL-C to decrease the risk for cardiovascular disease, particularly in our patients with diabetes? Learn from Margo B. Minissian, PhD, RN, ACNP-BC, NEA-BC, FAAN about the role of high blood sugar in cardiovascular disease, effective strategies for lowering LDL-C, and the importance of early treatment.
Related Resources:
PCNA Lipid Resources for Providers and Patients
PCNA Diabetes Resources for Providers and Patients
2018 AHA/ACC Guideline on the Management of Blood Cholesterol
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
IVUS Regression Trials: REVERSAL (2004), ASTEROID (2006); SATURN (2011); GLAGOV (2016); PRECISE-IVUS(2015); JAPAN-ACS (2009)
COURAGE trial
VESALIUS-CV trial
Pleiotropic effects of statins
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Preventive Cardiovascular Nurses AssociationWhat can we be doing to reduce LDL-C to decrease the risk for cardiovascular disease, particularly in our patients with diabetes? Learn from Margo B. Minissian, PhD, RN, ACNP-BC, NEA-BC, FAAN about the role of high blood sugar in cardiovascular disease, effective strategies for lowering LDL-C, and the importance of early treatment.
Related Resources:
PCNA Lipid Resources for Providers and Patients
PCNA Diabetes Resources for Providers and Patients
2018 AHA/ACC Guideline on the Management of Blood Cholesterol
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
IVUS Regression Trials: REVERSAL (2004), ASTEROID (2006); SATURN (2011); GLAGOV (2016); PRECISE-IVUS(2015); JAPAN-ACS (2009)
COURAGE trial
VESALIUS-CV trial
Pleiotropic effects of statins
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.